Process View
36 genes annotated in human
DOID:612
An immune system disease that results when one or more essential parts of the immune system is missing or not working properly at birth due to a genetic mutation.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "primary immunodeficiency disease"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
NCF1 | neutrophil cytosolic factor 1 | 1.000 | ||
NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 1.000 | Human | |
NCF4 | neutrophil cytosolic factor 4, 40kDa | 1.000 | ||
REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.999 | Human | |
TAP2 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) | 0.988 | ||
CYBA | cytochrome b-245, alpha polypeptide | 0.987 | ||
TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.984 | ||
NCF2 | neutrophil cytosolic factor 2 | 0.971 | ||
TAPBP | TAP binding protein (tapasin) | 0.968 | ||
CD79A | CD79a molecule, immunoglobulin-associated alpha | 0.964 | ||
BLNK | B-cell linker | 0.933 | ||
BTK | Bruton agammaglobulinemia tyrosine kinase | 0.931 | ||
APLF | aprataxin and PNKP like factor | 0.902 | ||
RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.877 | Human | |
CD19 | CD19 molecule | 0.792 | ||
BCL3 | B-cell CLL/lymphoma 3 | 0.791 | ||
PRKCB | protein kinase C, beta | 0.769 | ||
PSMB9 | proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) | 0.760 | ||
CD22 | CD22 molecule | 0.608 | ||
TRIM9 | tripartite motif containing 9 | 0.562 | ||
CD79B | CD79b molecule, immunoglobulin-associated beta | 0.534 | ||
PSMB8 | proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) | 0.522 | ||
NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.472 | ||
NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.468 | ||
RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.432 | Human | |
SYK | spleen tyrosine kinase | 0.364 | ||
TNIP2 | TNFAIP3 interacting protein 2 | 0.313 | ||
PRKCA | protein kinase C, alpha | 0.259 | ||
CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.225 | ||
ACTB | actin, beta | 0.220 | ||
IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.188 | ||
RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.187 | ||
HLA-A | major histocompatibility complex, class I, A | 0.184 | ||
GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.178 | ||
XRCC4 | X-ray repair complementing defective repair in Chinese hamster cells 4 | 0.151 | ||
MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.148 | ||
CDCP1 | CUB domain containing protein 1 | 0.146 | ||
PRKCD | protein kinase C, delta | 0.127 | ||
BLK | B lymphoid tyrosine kinase | 0.119 | Human | |
HLA-F | major histocompatibility complex, class I, F | 0.113 | ||
TSPAN4 | tetraspanin 4 | 0.099 | ||
NFKBIB | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta | 0.096 | ||
MZB1 | marginal zone B and B1 cell-specific protein | 0.096 | ||
IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.093 | ||
INO80B | INO80 complex subunit B | 0.090 | ||
FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.089 | ||
HLA-G | major histocompatibility complex, class I, G | 0.079 | ||
PDIA3 | protein disulfide isomerase family A, member 3 | 0.079 | ||
NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.078 | ||
IL4R | interleukin 4 receptor | 0.076 | ||
CAPN1 | calpain 1, (mu/I) large subunit | 0.076 | ||
B2M | beta-2-microglobulin | 0.075 | ||
TNFSF13B | tumor necrosis factor (ligand) superfamily, member 13b | 0.074 | ||
CD9 | CD9 molecule | 0.073 | Human | |
SPIB | Spi-B transcription factor (Spi-1/PU.1 related) | 0.073 | ||
TCL1A | T-cell leukemia/lymphoma 1A | 0.070 | ||
POU2AF1 | POU class 2 associating factor 1 | 0.067 | ||
MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.057 | ||
CXCR5 | chemokine (C-X-C motif) receptor 5 | 0.053 | ||
FAIM3 | Fas apoptotic inhibitory molecule 3 | 0.051 | ||
TNIP1 | TNFAIP3 interacting protein 1 | 0.043 | ||
VPREB3 | pre-B lymphocyte 3 | 0.043 | ||
HLA-C | major histocompatibility complex, class I, C | 0.040 | ||
IRF1 | interferon regulatory factor 1 | 0.040 | ||
IL32 | interleukin 32 | 0.038 | ||
ARID3A | AT rich interactive domain 3A (BRIGHT-like) | 0.037 | ||
FCER1G | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 0.037 | ||
PPIF | peptidylprolyl isomerase F | 0.035 | ||
PNOC | prepronociceptin | 0.034 | ||
LY86 | lymphocyte antigen 86 | 0.034 | ||
C3 | complement component 3 | 0.033 | Human | |
CD1C | CD1c molecule | 0.031 | ||
CD27 | CD27 molecule | 0.031 | ||
PLCG2 | phospholipase C, gamma 2 (phosphatidylinositol-specific) | 0.031 | ||
HLA-E | major histocompatibility complex, class I, E | 0.029 | ||
SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.029 | ||
NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.029 | ||
TNFRSF17 | tumor necrosis factor receptor superfamily, member 17 | 0.028 | ||
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.028 | ||
IL7R | interleukin 7 receptor | 0.028 | ||
IGL@ | immunoglobulin lambda locus | 0.027 | ||
CD99 | CD99 molecule | 0.026 | ||
IRF8 | interferon regulatory factor 8 | 0.026 | ||
LTB | lymphotoxin beta (TNF superfamily, member 3) | 0.026 | ||
SELL | selectin L | 0.025 | ||
STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.024 | Human | |
MSN | moesin | 0.024 | ||
HLA-DOB | major histocompatibility complex, class II, DO beta | 0.024 | ||
PSME1 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) | 0.024 | ||
TAGLN2 | transgelin 2 | 0.024 | ||
CD72 | CD72 molecule | 0.023 | ||
MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.023 | ||
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.023 | ||
RFX5 | regulatory factor X, 5 (influences HLA class II expression) | 0.023 | ||
STAP1 | signal transducing adaptor family member 1 | 0.022 | ||
IGJ | immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides | 0.022 | ||
CD180 | CD180 molecule | 0.022 | ||
PASK | PAS domain containing serine/threonine kinase | 0.022 | ||
IRF4 | interferon regulatory factor 4 | 0.022 | ||
TRAF5 | TNF receptor-associated factor 5 | 0.021 | ||
PSME2 | proteasome (prosome, macropain) activator subunit 2 (PA28 beta) | 0.021 | ||
ZC3H12A | zinc finger CCCH-type containing 12A | 0.021 | ||
RHOH | ras homolog gene family, member H | 0.021 | ||
SH3BP5 | SH3-domain binding protein 5 (BTK-associated) | 0.021 | ||
STK10 | serine/threonine kinase 10 | 0.021 | ||
NHEJ1 | nonhomologous end-joining factor 1 | 0.021 | ||
GLA | galactosidase, alpha | 0.020 | ||
CCR2 | chemokine (C-C motif) receptor 2 | 0.020 | ||
GFI1 | growth factor independent 1 transcription repressor | 0.020 | ||
HLA-B | major histocompatibility complex, class I, B | 0.019 | ||
CALR | calreticulin | 0.019 | ||
HLA-DOA | major histocompatibility complex, class II, DO alpha | 0.019 | ||
FLNA | filamin A, alpha | 0.018 | ||
SOCS1 | suppressor of cytokine signaling 1 | 0.018 | ||
CD86 | CD86 molecule | 0.018 | ||
HLA-DMA | major histocompatibility complex, class II, DM alpha | 0.018 | ||
TRAF3 | TNF receptor-associated factor 3 | 0.018 | ||
UBASH3B | ubiquitin associated and SH3 domain containing B | 0.018 | ||
PAX5 | paired box 5 | 0.017 | ||
CBLB | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 0.017 | ||
PIM2 | pim-2 oncogene | 0.017 | ||
GPR18 | G protein-coupled receptor 18 | 0.017 | ||
THOC5 | THO complex 5 | 0.017 | ||
GRPEL1 | GrpE-like 1, mitochondrial (E. coli) | 0.016 | ||
CR2 | complement component (3d/Epstein Barr virus) receptor 2 | 0.016 | ||
MAP3K14 | mitogen-activated protein kinase kinase kinase 14 | 0.015 | ||
CD52 | CD52 molecule | 0.015 | ||
LRMP | lymphoid-restricted membrane protein | 0.015 | ||
CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.015 | ||
ZNF259 | zinc finger protein 259 | 0.015 | ||
DLG5 | discs, large homolog 5 (Drosophila) | 0.014 | ||
INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.014 | ||
SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.014 | ||
CSF2RA | colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) | 0.014 | ||
HLA-DMB | major histocompatibility complex, class II, DM beta | 0.014 | ||
SASH3 | SAM and SH3 domain containing 3 | 0.014 | ||
CSF2RB | colony stimulating factor 2 receptor, beta, low-affinity (granulocyte-macrophage) | 0.014 | ||
CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.014 | ||
CCR7 | chemokine (C-C motif) receptor 7 | 0.014 | ||
PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.014 | ||
FASLG | Fas ligand (TNF superfamily, member 6) | 0.013 | ||
ITK | IL2-inducible T-cell kinase | 0.013 | ||
MATK | megakaryocyte-associated tyrosine kinase | 0.013 | ||
P2RX5 | purinergic receptor P2X, ligand-gated ion channel, 5 | 0.013 | ||
ADAMDEC1 | ADAM-like, decysin 1 | 0.013 | ||
FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.013 | Human | |
SIT1 | signaling threshold regulating transmembrane adaptor 1 | 0.013 | ||
IL2RA | interleukin 2 receptor, alpha | 0.012 | ||
IKZF1 | IKAROS family zinc finger 1 (Ikaros) | 0.012 | ||
FAS | Fas (TNF receptor superfamily, member 6) | 0.012 | ||
GNB1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 | 0.012 | ||
CD37 | CD37 molecule | 0.012 | ||
PSMB10 | proteasome (prosome, macropain) subunit, beta type, 10 | 0.012 | ||
TRAF3IP3 | TRAF3 interacting protein 3 | 0.012 | ||
CD2AP | CD2-associated protein | 0.012 | ||
ACTN4 | actinin, alpha 4 | 0.012 | ||
CD38 | CD38 molecule | 0.012 | ||
GTF2I | general transcription factor IIi | 0.012 | ||
FAM65B | family with sequence similarity 65, member B | 0.012 | ||
CCR6 | chemokine (C-C motif) receptor 6 | 0.012 | ||
TRAF4 | TNF receptor-associated factor 4 | 0.012 | ||
LAT2 | linker for activation of T cells family, member 2 | 0.012 | ||
DDOST | dolichyl-diphosphooligosaccharide--protein glycosyltransferase | 0.012 | ||
CHUK | conserved helix-loop-helix ubiquitous kinase | 0.012 | ||
FCRLA | Fc receptor-like A | 0.012 | ||
VPREB1 | pre-B lymphocyte 1 | 0.012 | ||
ZHX1 | zinc fingers and homeoboxes 1 | 0.011 | ||
IKZF3 | IKAROS family zinc finger 3 (Aiolos) | 0.011 | ||
HCP5 | HLA complex P5 | 0.011 | ||
TIFA | TRAF-interacting protein with forkhead-associated domain | 0.011 | ||
CUTA | cutA divalent cation tolerance homolog (E. coli) | 0.011 | ||
BANK1 | B-cell scaffold protein with ankyrin repeats 1 | 0.011 | ||
IKBKE | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase epsilon | 0.011 | ||
MAPKAPK3 | mitogen-activated protein kinase-activated protein kinase 3 | 0.011 | ||
ERMP1 | endoplasmic reticulum metallopeptidase 1 | 0.011 | ||
TNFSF13 | tumor necrosis factor (ligand) superfamily, member 13 | 0.011 | ||
CPT1A | carnitine palmitoyltransferase 1A (liver) | 0.011 | ||
SIRT6 | sirtuin 6 | 0.011 | ||
FCRL2 | Fc receptor-like 2 | 0.011 | ||
IL7 | interleukin 7 | 0.011 | ||
GP1BB | glycoprotein Ib (platelet), beta polypeptide | 0.011 | ||
SBNO2 | strawberry notch homolog 2 (Drosophila) | 0.011 | ||
LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.011 | ||
HK2 | hexokinase 2 | 0.011 | ||
RGS14 | regulator of G-protein signaling 14 | 0.011 | ||
PLXND1 | plexin D1 | 0.011 | ||
CD2 | CD2 molecule | 0.011 | ||
WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.011 | ||
CD151 | CD151 molecule (Raph blood group) | 0.010 | ||
GADD45GIP1 | growth arrest and DNA-damage-inducible, gamma interacting protein 1 | 0.010 | ||
HP | haptoglobin | 0.010 | ||
HLA-DRB4 | major histocompatibility complex, class II, DR beta 4 | 0.010 | ||
HCK | hemopoietic cell kinase | 0.010 | Human | |
LCP1 | lymphocyte cytosolic protein 1 (L-plastin) | 0.010 | ||
IL2RG | interleukin 2 receptor, gamma | 0.009 | ||
RFXAP | regulatory factor X-associated protein | 0.008 | ||
IGLL1 | immunoglobulin lambda-like polypeptide 1 | 0.008 | ||
ADA | adenosine deaminase | 0.007 | ||
CIITA | class II, major histocompatibility complex, transactivator | 0.007 | ||
CYBB | cytochrome b-245, beta polypeptide | 0.007 | ||
C5 | complement component 5 | 0.006 | ||
ICOS | inducible T-cell co-stimulator | 0.005 | ||
TNFRSF13B | tumor necrosis factor receptor superfamily, member 13B | 0.005 | ||
RFXANK | regulatory factor X-associated ankyrin-containing protein | 0.005 | ||
CFI | complement factor I | 0.004 | ||
STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.004 | ||
LRRC8A | leucine rich repeat containing 8 family, member A | 0.003 | ||
TNFRSF13C | tumor necrosis factor receptor superfamily, member 13C | 0.003 | ||
LIG4 | ligase IV, DNA, ATP-dependent | 0.003 | ||
LRBA | LPS-responsive vesicle trafficking, beach and anchor containing | 0.003 | ||
CD81 | CD81 molecule | 0.002 | ||
TBX1 | T-box 1 | 0.001 | ||
PNP | purine nucleoside phosphorylase | 0.001 | ||
AK2 | adenylate kinase 2 | 0.001 |